Form 8-K - Current report:
SEC Accession No. 0001140361-18-043530
Filing Date
2018-11-21
Accepted
2018-11-20 20:52:23
Documents
12
Period of Report
2018-11-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s002354x7_8k.htm 8-K 19940
2 EXHIBIT 99.1 s002354x7_ex99-1.htm EX-99.1 69320
3 s002354x7_ex99-1logo01.jpg GRAPHIC 76374
4 s002354x7_ex99-1logo02.jpg GRAPHIC 4993
5 s002354x7_ex99-1logo03.jpg GRAPHIC 152442
6 s002354x7_ex99-1logo04.jpg GRAPHIC 137861
7 s002354x7_ex99-1logo05.jpg GRAPHIC 65746
8 s002354x7_ex99-1logo06.jpg GRAPHIC 38911
9 s002354x7_ex99-1logo07.jpg GRAPHIC 25612
10 s002354x7_ex99-1logo08.jpg GRAPHIC 20485
11 s002354x7_ex99-1logo09.jpg GRAPHIC 11804
12 s002354x7_ex99-1sig.jpg GRAPHIC 80280
  Complete submission text file 0001140361-18-043530.txt   937843
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 181196801
SIC: 3841 Surgical & Medical Instruments & Apparatus